U.S. market Closed. Opens in 1 day 14 hours 22 minutes

ENSC | Ensysce Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue2.23M2.52M3.53M3.93M1.76MN/AN/A
Cost of Revenue7.59M19.84M151.001.37M3.33M1.56MN/A
Gross Profit-5.36M-17.31M3.53M2.56M-1.56M-1.56MN/A
Operating Expenses5.36M24.22M19.87M1.61M3.33M959.25K146.69K
Selling, General & Admin5.36M6.91M18.71M1.15M3.33M1.56M146.69K
Research & Development7.59M19.84M4.69M4.39M3.40MN/AN/A
Other Operating Expenses-7.59M-2.52M-3.53M-3.93MN/A600.00KN/A
Operating Income-10.72M-24.22M-19.87M-1.61M-3.33M-959.24K-146.70K
Other Expenses / Income91.91K14.41K-9.28M1.45M4.25M3.64M119.14K
Before Tax Income-10.63M-24.21M-29.15M-160.88K921.15K2.68M-27.56K
Income Tax ExpensesN/A753.88K-151.00777.85K-555.20K553.92K3.63K
Net Income-10.61M-24.96M-29.15M-938.73K1.48M-1.34M-31.19K
Interest Expenses353.94K109.53K1.30M995.50KN/AN/AN/A
Basic Shares Outstanding2.26M179.93K84.02K65.70K98.26K104.02K105.00K
Diluted Shares Outstanding2.26M179.93K84.02K68.78K98.26K104.02K105.00K
EBITDA-10.72M-24.22M-19.87M-1.61M921.15K2.68M-27.55K
EBITDA Margin-480.52%-959.91%-562.71%-41.03%52.22%0.00%0.00%
EBIT-10.26M-24.10M-27.85M834.62K921.15K-788.77K-27.56K
EBIT Margin-459.94%-954.99%-788.70%21.23%52.22%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙